[go: up one dir, main page]

AU2002224139A1 - Ppar (peroxisome proliferator activated receptor) activators - Google Patents

Ppar (peroxisome proliferator activated receptor) activators

Info

Publication number
AU2002224139A1
AU2002224139A1 AU2002224139A AU2413902A AU2002224139A1 AU 2002224139 A1 AU2002224139 A1 AU 2002224139A1 AU 2002224139 A AU2002224139 A AU 2002224139A AU 2413902 A AU2413902 A AU 2413902A AU 2002224139 A1 AU2002224139 A1 AU 2002224139A1
Authority
AU
Australia
Prior art keywords
ppar
activators
activated receptor
peroxisome proliferator
proliferator activated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002224139A
Inventor
Tsuyoshi Endo
Takashi Kanda
Kunio Kobayashi
Seiichiro Masui
Nobutaka Mochiduki
Shogo Sakuma
Toshihiro Takahashi
Atsushi Tendo
Tomio Yamakawa
Shinichi Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Chemiphar Co Ltd
Original Assignee
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co Ltd filed Critical Nippon Chemiphar Co Ltd
Publication of AU2002224139A1 publication Critical patent/AU2002224139A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002224139A 2000-12-05 2001-12-04 Ppar (peroxisome proliferator activated receptor) activators Abandoned AU2002224139A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-369891 2000-12-05
JP2000369891 2000-12-05
PCT/JP2001/010577 WO2002046176A1 (en) 2000-12-05 2001-12-04 Ppar (peroxisome proliferator activated receptor) activators

Publications (1)

Publication Number Publication Date
AU2002224139A1 true AU2002224139A1 (en) 2002-06-18

Family

ID=18839861

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002224139A Abandoned AU2002224139A1 (en) 2000-12-05 2001-12-04 Ppar (peroxisome proliferator activated receptor) activators

Country Status (3)

Country Link
JP (1) JPWO2002046176A1 (en)
AU (1) AU2002224139A1 (en)
WO (1) WO2002046176A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4383177B2 (en) * 2002-03-01 2009-12-16 スミスクライン ビーチャム コーポレーション hPPAR activator
ES2535975T3 (en) 2002-10-03 2015-05-19 Novaremed Ltd. Compounds for use in the treatment of autoimmune diseases, immunoallergic diseases and rejection of organ or tissue transplants
US6653334B1 (en) 2002-12-27 2003-11-25 Kowa Co., Ltd. Benzoxazole compound and pharmaceutical composition containing the same
WO2004071509A1 (en) * 2003-02-12 2004-08-26 Nippon Chemiphar Co., Ltd. Oligodendrocyte differentiation promoters
CN1791409A (en) * 2003-04-17 2006-06-21 凯利普西斯公司 (3-{3-' (2,4-bis- trifluormethyl -benzyl)-(5 -ethyl-pyrimidin -2-yl)- amino! -propoxy} -phenyl) -acetic acid and related compounds as modulators of ppars and methods of treating metabolic disorders
WO2005023777A1 (en) * 2003-09-03 2005-03-17 Kowa Co., Ltd. Ppar-activating compound and pharmaceutical composition containing same
CN100425594C (en) * 2003-09-03 2008-10-15 兴和株式会社 PPAR activating compound and pharmaceutical composition containing the same
JP4939396B2 (en) 2004-03-26 2012-05-23 ノヴァレメッド リミテッド Compounds for improving or treating AIDS and other viral diseases and HIV-related infectious diseases and compositions thereof, compositions containing such compounds, methods for treating such diseases and infectious diseases, and methods for producing such compounds and compositions
EP2305352A1 (en) 2004-04-02 2011-04-06 Merck Sharp & Dohme Corp. 5-alpha-reductase inhibitors for use in the treatment of men with metabolic and anthropometric disorders
DE102004016845A1 (en) * 2004-04-07 2005-10-27 Bayer Healthcare Ag Phenylthioacetic acid derivatives and their use
US7301033B2 (en) 2005-01-27 2007-11-27 Kowa Co., Ltd. PPAR-activating compound
WO2006090768A1 (en) * 2005-02-23 2006-08-31 Kowa Co., Ltd. Process for production of optically active ppar-activating compound and intermediate of the same
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
EP2348857B1 (en) 2008-10-22 2016-02-24 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
AU2009309037A1 (en) 2008-10-31 2010-05-06 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
JP2013520502A (en) 2010-02-25 2013-06-06 メルク・シャープ・エンド・ドーム・コーポレイション Novel cyclic benzimidazole derivatives that are useful anti-diabetic drugs
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
JP5728099B2 (en) 2011-02-25 2015-06-03 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． Novel cyclic azabenzimidazole derivatives useful as antidiabetic agents
RU2015106909A (en) 2012-08-02 2016-09-27 Мерк Шарп И Доум Корп. ANTI-DIABETIC TRICYCLIC COMPOUNDS
WO2014130608A1 (en) 2013-02-22 2014-08-28 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
EP2970119B1 (en) 2013-03-14 2021-11-03 Merck Sharp & Dohme Corp. Novel indole derivatives useful as anti-diabetic agents
WO2015051496A1 (en) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
KR102556214B1 (en) * 2016-07-08 2023-07-19 주식회사유한양행 Benzo[d]thiazole derivative or its salt and pharmaceutical composition comprising the same
EP3551176A4 (en) 2016-12-06 2020-06-24 Merck Sharp & Dohme Corp. ANTIDIABETIC HETEROCYCLIC COMPOUNDS
WO2018118670A1 (en) 2016-12-20 2018-06-28 Merck Sharp & Dohme Corp. Antidiabetic spirochroman compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2541342A1 (en) * 1975-09-17 1977-03-31 Boehringer Mannheim Gmbh NEW PHENOXYALKYLCARBONIC ACIDS AND METHOD FOR PREPARING THE SAME
DE3835660A1 (en) * 1988-03-25 1989-10-12 Bayer Ag 7-SUBSTITUTED 2-CARBONAMIDO-BENZTHIAZOL-3-OXIDES
GB9027023D0 (en) * 1990-12-12 1991-01-30 Wellcome Found Anti-atherosclerotic aryl compounds
JPH10182459A (en) * 1996-12-26 1998-07-07 Otsuka Pharmaceut Co Ltd Cgmp phosphodiesterase inhibitor

Also Published As

Publication number Publication date
JPWO2002046176A1 (en) 2004-04-08
WO2002046176A1 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
AU2002224139A1 (en) Ppar (peroxisome proliferator activated receptor) activators
AU2002224138A1 (en) Peroxisome proliferator activated receptor d activators
AU2001242747A1 (en) Activators for peroxisome proliferator activated receptor delta (ppardelta)
MXPA03004141A (en) Peroxisome proliferator activated receptor alpha agonists.
AU2002323776A1 (en) Activator for peroxisome proliferator-responsive receptor Delta
AU2002335231A1 (en) Activator for peroxisome proliferator-activated receptor delta
AU2001238339A1 (en) Dispenser for fluid materials
IL158873A0 (en) Modulators of peroxisome proliferator activated receptors
AU2001227839A1 (en) Shower head
IL161578A0 (en) Peroxisome proliferator activated receptor agonists
AU775774C (en) Peroxisome proliferator-activated receptor agonist
AU5034101A (en) Shower head for a sanitary shower
AU2001239773A1 (en) Baroplastic materials
AU2001292285A1 (en) Thiazole or oxazole derivatives
AU2002347985A1 (en) Peroxisome proliferator activated receptor alpha agonists
AUPQ138899A0 (en) Sanitary apparatus
AU2001248820A1 (en) Thiazole and oxazole derivatives
AU2003278814A1 (en) Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof
AU2002212498A1 (en) Fluid machine
AU3944501A (en) Articulated pigging device
AU5531900A (en) Device for taking care of objects, comprising a scraper element
AU2001223882A1 (en) Receptor
AUPQ563400A0 (en) Novel receptor
AU7961800A (en) Thiazolidinedione derivatives
HK1071563A (en) Peroxisome proliferator activated receptor agonists